The legislature is likely to pass a draft bill in the upcoming session allowing manufacturers of high-risk medical devices to receive tax reductions and government subsidies, Legislative Speaker Wang Jin-pyng (王金平) said yesterday.
“There is a consensus among legislators for such initiative, so we think it should not be a problem,” Wang said on the sidelines of a meeting for the review of biotechnology policies.
The bill would grant these companies tax reduction for their research and development expenditure and spending on personnel training, according to the government-funded Institute for Biotechnology and Medicine Industry, which proposed the bill to the government.
Furthermore, the bill will increase subsidies for local medical device makers to 25 percent of government subsidies for biotechnology industry from 8 percent, Wu Ming-fa (吳明發), chief executive officer of the biotech institute, said by telephone .
The bill would expand the coverage of the Act For The Development Of Biotech And New Pharmaceuticals Industry (生技新藥產業發展條例) to 56 percent of local medical device producers from 7 percent, the Chinese-language Commercial Times said.
The government on Saturday failed to meet the timetable it had set a year ago to include companies making Class 2 medical devices, such as disposable contact lenses, under the act.
The government promised on Aug. 31 last year to add 33 suggestions made by pharmaceutical companies into the act, and it will continue implementing these changes suggested by companies, Minister Without Portfolio Simon Chang (張善政) said at the meeting.
Meanwhile, biomedical group Microbio (中天) chairman Lu Kung-ming (路孔明) yesterday criticized the government for failing to reach an agreement with Chinese government to set up a unified standard for drug companies across the Taiwan Strait.
In response, Premier Jiang Yi-huah (江宜樺) said he had discussed the issue with the Mainland Affairs Council and Ministry of Health and Welfare, and would conduct further talks with the Chinese government.
Local vaccine maker Adimmune Corp (國光生技) chairman Steve Chan (詹啟賢) said a meeting between Taiwanese and Chinese companies and officials is to take place on Nov. 8 and Nov. 9 in China.
“The talk is likely to facilitate establishing a standard agreed by both sides concerning new drug applications, but it will still require both governments’ approvals for such a deal to be realized,” Chan said.
China has claimed a breakthrough in developing homegrown chipmaking equipment, an important step in overcoming US sanctions designed to thwart Beijing’s semiconductor goals. State-linked organizations are advised to use a new laser-based immersion lithography machine with a resolution of 65 nanometers or better, the Chinese Ministry of Industry and Information Technology (MIIT) said in an announcement this month. Although the note does not specify the supplier, the spec marks a significant step up from the previous most advanced indigenous equipment — developed by Shanghai Micro Electronics Equipment Group Co (SMEE, 上海微電子) — which stood at about 90 nanometers. MIIT’s claimed advances last
ISSUES: Gogoro has been struggling with ballooning losses and was recently embroiled in alleged subsidy fraud, using Chinese-made components instead of locally made parts Gogoro Inc (睿能創意), the nation’s biggest electric scooter maker, yesterday said that its chairman and CEO Horace Luke (陸學森) has resigned amid chronic losses and probes into the company’s alleged involvement in subsidy fraud. The board of directors nominated Reuntex Group (潤泰集團) general counsel Tamon Tseng (曾夢達) as the company’s new chairman, Gogoro said in a statement. Ruentex is Gogoro’s biggest stakeholder. Gogoro Taiwan general manager Henry Chiang (姜家煒) is to serve as acting CEO during the interim period, the statement said. Luke’s departure came as a bombshell yesterday. As a company founder, he has played a key role in pushing for the
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has appointed Rose Castanares, executive vice president of TSMC Arizona, as president of the subsidiary, which is responsible for carrying out massive investments by the Taiwanese tech giant in the US state, the company said in a statement yesterday. Castanares will succeed Brian Harrison as president of the Arizona subsidiary on Oct. 1 after the incumbent president steps down from the position with a transfer to the Arizona CEO office to serve as an advisor to TSMC Arizona’s chairman, the statement said. According to TSMC, Harrison is scheduled to retire on Dec. 31. Castanares joined TSMC in
EUROPE ON HOLD: Among a flurry of announcements, Intel said it would postpone new factories in Germany and Poland, but remains committed to its US expansion Intel Corp chief executive officer Pat Gelsinger has landed Amazon.com Inc’s Amazon Web Services (AWS) as a customer for the company’s manufacturing business, potentially bringing work to new plants under construction in the US and boosting his efforts to turn around the embattled chipmaker. Intel and AWS are to coinvest in a custom semiconductor for artificial intelligence computing — what is known as a fabric chip — in a “multiyear, multibillion-dollar framework,” Intel said in a statement on Monday. The work would rely on Intel’s 18A process, an advanced chipmaking technology. Intel shares rose more than 8 percent in late trading after the